サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1782975

OVD（粘弾性物質）の世界市場

Ophthalmic Viscosurgical Devices

出版日
ページ情報
英文 375 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.46円
OVD（粘弾性物質）の世界市場
出版日: 2025年08月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 375 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

OVD（粘弾性物質）の世界市場は2030年までに5億6,430万米ドルに達する見込み

2024年に4億2,980万米ドルと推定されるOVD（粘弾性物質）の世界市場は、2030年には5億6,430万米ドルに達し、分析期間2024-2030年のCAGRは4.6%で成長すると予測されます。本レポートで分析したセグメントの1つである分散型OVD（粘弾性物質）は、CAGR 3.6％を記録し、分析期間終了時には2億9,380万米ドルに達すると予測されています。凝集性OVD（粘弾性物質）分野の成長率は、分析期間中CAGR 6.0％と推定されます。

米国市場は1億1,710万米ドルと推定、中国はCAGR 7.2％で成長予測

米国のOVD（粘弾性物質）市場は、2024年に1億1,710万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを7.2%として、2030年までに1億960万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.3%と4.6%と予測されています。欧州では、ドイツがCAGR 2.9%で成長すると予測されています。

世界のOVD（粘弾性物質）市場- 主要動向と促進要因まとめ

現代の眼科手術に粘液手術装置が欠かせない理由とは？

OVD（粘弾性物質）は、術中に重要なサポートを提供することで、眼科手術、特に白内障手術の要としての地位を確立しています。一般的にヒアルロン酸ナトリウムやその他の粘弾性化合物からなるこれらのゲル状物質は、前房の安定性を維持し、眼内組織を保護し、眼内レンズ（IOL）の移植を容易にするために不可欠です。白内障手術は世界中で最も頻繁に行われている手術の一つであり、信頼性が高く高性能のOVDに対する需要は並行して高まり続けています。緑内障フィルター手術、角膜移植、網膜硝子体手術などの複雑な手術では、組織の保護と空間の維持が重要となるため、その役割はさらに重要になります。手術手技がマイクロ切開やフェムト秒レーザー支援手技へと進化するにつれて、高純度で相特異的なOVDへの依存度が高まっています。この動向は、世界の老年人口の増加によって強化され、加齢に関連した眼科医療介入を必要とする患者層が拡大しています。さらに、術後の転帰と患者の安全性が一貫して重視されているため、外科医は内皮の損傷や炎症を抑える高度なOVDを採用するようになっています。このように、これらのデバイスは手術の観点から不可欠であるだけでなく、視力アウトカムと回復プロファイルの改善に焦点を当てたプロトコルにますます組み込まれるようになってきています。

製品革新はどのようにOVDの性能を高めているのか？

OVD（粘弾性物質）における技術革新は、手術の精度、安全性、効率性を再構築しています。最も重要な進歩のひとつは、一度の塗布で空間維持と組織保護の両方の利点を提供するデュアルファンクションOVDの開発です。このような製剤は、手術プロセスを簡略化し、複数の製品を投与する必要性を減らします。また、メーカーは粘弾性体の分子構造を改良し、流動ダイナミクスを改善し、透明性を高め、前房内での滞留性を高めています。このような改良により、特に小瞳孔や虹彩縮小症（floppy iris syndrome）のような複雑な症例において、超音波乳化吸引術や眼内レンズ挿入時に眼構造をより適切に操作することができるようになりました。さらに、プレフィルドシリンジや人間工学に基づいた送達システムが導入され、処置中の取り扱いが改善され、廃棄物が最小限に抑えられています。架橋ヒアルロン酸製剤の進歩は、長期間の保持とストレス下でのより良い粘弾性挙動に寄与しており、最新の高速手術手技のニーズに合致しています。生体適合性は依然として主要な重点分野であり、炎症、眼圧上昇、および術後合併症のリスクをさらに減らすことを目指した技術革新が行われています。さらに、術中に機械的および薬理学的な利点をもたらす可能性のある生分解性OVDや薬剤溶出性OVDの研究も進行中です。このような技術的進歩は、手術成績を向上させるだけでなく、競合市場情勢における差別化にもつながっています。

需要パターンを決定しているエンドユーザーと地域の動向は？

OVD（粘弾性物質）の需要は、エンドユーザーの嗜好と地域のヘルスケア開発の両方から強い影響を受けています。手術インフラが発達し、患者の期待が高い高所得国では、眼科外科医が性能と安全性を高めたプレミアムOVDを好む傾向が強まっています。米国、ドイツ、日本などの国々では、眼科センターが整備され、手術件数が多いため、高級ブランドOVDの安定した消費が保証されています。対照的に、インド、ブラジル、東南アジアなどの新興市場では、白内障手術件数の増加、医療アクセスの改善、政府による失明予防イニシアチブを背景に、急速な導入が進んでいます。これらの地域では、大量の眼科医療プログラムや移動式手術キャンプをサポートするために、費用対効果が高く信頼性の高いOVDが求められています。外来手術センターや独立型眼科クリニックの増加も、迅速な交換を可能にし、汚染リスクを低減する滅菌済み単回使用OVDの購買層を拡大しています。学術機関や手術トレーニングセンターは、標準化された手術教育プロトコルにOVDの使用を組み込んでいるため、さらに需要に貢献しています。さらに、プライベート・エクイティが支援する眼科チェーンやフランチャイズのビジョンケア・ネットワークの台頭は、OVDブランドの集中調達と標準化につながり、大手メーカーの市場認知度を高めています。これらの動向は、さまざまな市場層でより戦略的で量的な購買行動への明確なシフトを強調しています。

OVD（粘弾性物質）市場の成長を促進する主な要因とは？

OVD（粘弾性物質）市場の成長は、技術の改良、手術件数の拡大、臨床診療基準のシフトに関連するいくつかの要因によってもたらされます。主な成長要因の1つは、平均寿命の伸びと早期の視力回復オプションに対する意識の高まりに支えられた白内障手術の世界の増加です。低侵襲手術やレーザー支援手術への移行により、術中の急速な状況下でも保持力、透明性、チャンバー安定性を高めるOVDへの需要が高まっています。単回使用、無菌、プレフィルドのOVDに対するエンドユーザーの需要も、特に外来手術センターや高スループット手術センターで伸びています。二相性OVDや粘度適応型OVDなどの継続的な製品革新により、標準的なレンズ移植から高度な前・後セグメンテーションまで、より幅広い手術シナリオで臨床的有用性が拡大しています。新興市場では、公衆衛生プログラム、非政府主導、移動式手術ユニットなどによる視力ケアへのアクセスの拡大が、OVDの大量消費を促進しています。さらに、眼科機器メーカーと製薬会社の戦略的提携により、製品のバンドルや統合された手術の提供が強化されています。眼科におけるトレーニングプログラムやシミュレーションベースの教育が浸透しつつあることで、OVDの高度な使用法に対する開業医の精通度と信頼度が高まっています。このような複合的な要因により、OVD（粘弾性物質）は世界の眼科医療における重要な成長要素となっています。

セグメント

タイプ（分散性、凝集性、粘着性）、供給源（生物由来、動物由来、半合成由来）、用途（白内障手術用途、角膜移植用途、緑内障手術用途、網膜硝子体移植用途）

調査対象企業の例

  • Advin Health Care
  • Alcon Inc.
  • Altacor Limited
  • Amring Pharmaceuticals Inc.
  • Bausch & Lomb Incorporated
  • Beaver-Visitec International Inc.
  • Bloomage Biotechnology Corporation Limited
  • Bohus Biotech AB
  • Carl Zeiss Meditec AG
  • CIMA Technology Inc.
  • Eyebright Medical Technology Co., Ltd.
  • Eyekon Medical Inc.
  • Haohai Biological Technology
  • Johnson & Johnson Surgical Vision, Inc.
  • Maxigen Biotech Inc.
  • Ophtechnics Unlimited
  • Rayner Intraocular Lenses Limited
  • RUMEX International Co.
  • Santen Pharmaceutical Co., Ltd.
  • Truviz Ophthalmic

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32432

Global Ophthalmic Viscosurgical Devices Market to Reach US$564.3 Million by 2030

The global market for Ophthalmic Viscosurgical Devices estimated at US$429.8 Million in the year 2024, is expected to reach US$564.3 Million by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Dispersive Ophthalmic Viscosurgical Devices, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$293.8 Million by the end of the analysis period. Growth in the Cohesive Ophthalmic Viscosurgical Devices segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$117.1 Million While China is Forecast to Grow at 7.2% CAGR

The Ophthalmic Viscosurgical Devices market in the U.S. is estimated at US$117.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$109.6 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Ophthalmic Viscosurgical Devices Market - Key Trends & Drivers Summarized

Why Are Viscosurgical Devices Indispensable in Modern Ocular Surgery?

Ophthalmic Viscosurgical Devices (OVDs) have established themselves as a cornerstone in ocular surgeries, particularly cataract procedures, by offering critical intraoperative support. These gel-like substances, typically composed of sodium hyaluronate or other viscoelastic compounds, are essential in maintaining anterior chamber stability, protecting intraocular tissues, and facilitating intraocular lens (IOL) implantation. With cataract surgery being one of the most frequently performed procedures worldwide, the demand for reliable and high-performing OVDs continues to grow in parallel. Their role is even more vital in complex surgeries such as glaucoma filtering procedures, corneal transplants, and vitreoretinal interventions, where tissue protection and space maintenance are critical. As surgical techniques evolve toward micro-incisional and femtosecond laser-assisted procedures, the reliance on high-purity, phase-specific OVDs is increasing. This trend is reinforced by the rising geriatric population globally, which presents a larger pool of patients requiring age-related eye care interventions. Moreover, the consistent emphasis on post-operative outcomes and patient safety is pushing surgeons to adopt advanced OVDs that reduce endothelial damage and inflammation. Thus, these devices are not only essential from a surgical standpoint but are also becoming increasingly integrated into protocols focused on improving visual outcomes and recovery profiles.

How Is Product Innovation Elevating the Performance of OVDs?

Innovation in ophthalmic viscosurgical devices is reshaping surgical precision, safety, and efficiency. One of the most significant advancements is the development of dual-function OVDs-also known as dispersive-cohesive combinations-which offer the benefits of both space maintenance and tissue protection in a single application. These formulations simplify the surgical process and reduce the need for multiple product administrations. Manufacturers are also refining the molecular structure of viscoelastics to improve flow dynamics, increase transparency, and enhance retention within the anterior chamber. These improvements allow for better manipulation of ocular structures during phacoemulsification and IOL placement, particularly in complex cases such as small pupil or floppy iris syndrome. Additionally, pre-filled syringes and ergonomic delivery systems are being introduced to improve handling and minimize waste during procedures. Advances in cross-linked hyaluronic acid formulations are contributing to prolonged retention and better viscoelastic behavior under stress, aligning with the needs of modern, high-speed surgical techniques. Biocompatibility remains a major focus area, with innovations aiming to further reduce the risk of inflammation, IOP spikes, and post-op complications. Furthermore, research is ongoing into biodegradable and drug-eluting OVDs that could provide both mechanical and pharmacological benefits intraoperatively. These technological strides are not only boosting surgical outcomes but are also creating differentiation in a competitive market landscape.

What End-Use and Geographic Trends Are Defining Demand Patterns?

Demand for ophthalmic viscosurgical devices is being strongly influenced by both end-user preferences and regional healthcare developments. In high-income countries, where surgical infrastructure is advanced and patient expectations are high, ophthalmic surgeons increasingly prefer premium OVDs that offer enhanced performance and safety. The presence of well-established ophthalmology centers and high surgical throughput in countries like the U.S., Germany, and Japan ensures steady consumption of high-grade, branded OVDs. In contrast, emerging markets such as India, Brazil, and parts of Southeast Asia are witnessing rapid adoption driven by rising cataract surgery volumes, improved healthcare access, and government-backed blindness prevention initiatives. In these regions, cost-effective yet reliable OVDs are in demand to support high-volume eye care programs and mobile surgical camps. The increasing number of ambulatory surgical centers and standalone eye clinics is also expanding the buyer base for single-use, pre-sterilized OVDs that enable fast turnover and reduce the risk of contamination. Academic institutions and surgical training centers further contribute to demand as they incorporate OVD use into standardized surgical education protocols. Additionally, the rise of private equity-backed ophthalmology chains and franchised vision care networks is leading to centralized procurement and standardization of OVD brands, increasing market visibility for leading manufacturers. These trends underscore a clear shift toward more strategic and volume-driven purchasing behavior across different market tiers.

What Key Forces Are Fueling Growth in the Ophthalmic Viscosurgical Devices Market?

The growth in the ophthalmic viscosurgical devices market is driven by several factors related to technological refinement, surgical volume expansion, and shifts in clinical practice standards. One of the primary growth drivers is the global increase in cataract surgeries, supported by rising life expectancy and growing awareness of early vision restoration options. The transition toward minimally invasive and laser-assisted surgical techniques is increasing demand for OVDs that offer enhanced retention, clarity, and chamber stability under rapid intraoperative conditions. End-user demand for single-use, sterile, and pre-filled OVD formats is also growing, especially in ambulatory and high-throughput surgical centers. Continued product innovation, including dual-phase and viscoadaptive OVDs, is expanding clinical utility across a broader range of surgical scenarios, from standard lens implantation to advanced anterior and posterior segment procedures. In emerging markets, the expansion of vision care access through public health programs, non-governmental initiatives, and mobile surgical units is driving significant volumes of OVD consumption. Additionally, strategic collaborations between ophthalmic equipment manufacturers and pharmaceutical companies are enhancing product bundling and integrated surgical offerings. The growing penetration of training programs and simulation-based education in ophthalmology is increasing practitioner familiarity and confidence with advanced OVD usage. These combined factors are positioning ophthalmic viscosurgical devices as a critical and growing component within the broader landscape of global eye care.

SCOPE OF STUDY:

The report analyzes the Ophthalmic Viscosurgical Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices, Viscoadaptive Ophthalmic Viscosurgical Devices); Source (Biological Source, Animal Source, Semi-Synthetic Source); Application (Cataract Surgery Application, Corneal Grafting Application, Glaucoma Surgery Application, Vitreoretinal Grafting Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

  • Advin Health Care
  • Alcon Inc.
  • Altacor Limited
  • Amring Pharmaceuticals Inc.
  • Bausch & Lomb Incorporated
  • Beaver-Visitec International Inc.
  • Bloomage Biotechnology Corporation Limited
  • Bohus Biotech AB
  • Carl Zeiss Meditec AG
  • CIMA Technology Inc.
  • Eyebright Medical Technology Co., Ltd.
  • Eyekon Medical Inc.
  • Haohai Biological Technology
  • Johnson & Johnson Surgical Vision, Inc.
  • Maxigen Biotech Inc.
  • Ophtechnics Unlimited
  • Rayner Intraocular Lenses Limited
  • RUMEX International Co.
  • Santen Pharmaceutical Co., Ltd.
  • Truviz Ophthalmic

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Ophthalmic Viscosurgical Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Cataract Surgery Rates Throw the Spotlight on High-Performance Ophthalmic Viscosurgical Devices (OVDs)
    • Growing Geriatric Population Spur Growth in Age-Related Eye Surgeries and Long-Term Use of Viscosurgical Aids
    • Minimally Invasive Surgical Techniques Expand Addressable Market Opportunity for Low-Viscosity and Dual-Function OVDs
    • Technological Innovations in Rheological Properties Strengthen the Business Case for Advanced Cohesive and Dispersive OVDs
    • Demand for Faster Recovery and Improved Outcomes Drives Adoption of Tissue-Protective, High-Purity OVD Formulations
    • Surge in Refractive and Glaucoma Surgeries Sustains Growth in Multifunctional Viscosurgical Product Portfolios
    • Customized OVD Use in Complex Surgeries Creates Opportunities for Procedure-Specific Product Development
    • Integration of Preloaded, Single-Use Delivery Systems Propels Growth in High-Volume, Ambulatory Surgical Centers
    • Expansion of Ophthalmic Services in Emerging Economies Generates Demand for Cost-Effective, Shelf-Stable OVDs
    • Advancement in Dual-Viscosity and Viscoadaptive Technologies Drive Clinical Efficiency and Reduce Surgical Time
    • Rising Focus on Standardization and Product Training Across Eye Care Chains Spurs Greater OVD Utilization
    • Shift Toward Personalized Eye Surgery Protocols Encourages Development of Indication-Specific Viscosurgical Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Ophthalmic Viscosurgical Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Dispersive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Dispersive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Dispersive Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cohesive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cohesive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cohesive Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Viscoadaptive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Viscoadaptive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Viscoadaptive Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vitreoretinal Grafting Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vitreoretinal Grafting Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Vitreoretinal Grafting Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cataract Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cataract Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cataract Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Corneal Grafting Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Corneal Grafting Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Corneal Grafting Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Glaucoma Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Glaucoma Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Glaucoma Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Biological Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Biological Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Biological Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Animal Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Animal Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Animal Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Semi-Synthetic Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Semi-Synthetic Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Semi-Synthetic Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • JAPAN
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • CHINA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • EUROPE
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • FRANCE
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • GERMANY
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • INDIA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • AFRICA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030

IV. COMPETITION